
Results
6
6 companies
Ascelia Pharma
Market Cap: SEK 366.0m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.89
7D
-3.4%
1Y
2.1%
Camurus
Market Cap: SEK 26.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 450.00
7D
0.2%
1Y
-21.0%
Devyser Diagnostics
Market Cap: SEK 1.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 75.90
7D
-1.4%
1Y
-26.7%
Bonesupport Holding
Market Cap: SEK 12.4b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 186.30
7D
5.6%
1Y
-37.8%
Guard Therapeutics International
Market Cap: SEK 29.7m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.48
7D
8.5%
1Y
-90.4%
IDL Diagnostics
Market Cap: SEK 65.9m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.29
7D
-10.1%
1Y
-49.4%